By Tomasz Burzykowski, Sr. Statistician MSOURCE and Associate Prof at the University of Hasselt
The contract research organisation (CRO) market was worth an estimated $14 billion in 2006 and is set to grow at an annual rate of 14-16 percent over the next few years to an estimated $24 billion by 2010.
Moss is important to greenovation Biotech. They have used it to establish several expression tools and need it for their unique photobioreactor, a major innovation in the manufacture of pharmaceuticals.
Novo Nordisk have set up a new direct access clinical trials website in order to share more information with patients, professionals and investors. Merete Jorgensen project manager for the site explains more…